Physician Wealth Advisors’s Sagimet Biosciences SGMT Stock Holding History

Physician Wealth Advisors’s Portfolio SGMT Stock Details SGMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.45K	Hold	317	–	–	﹤0.01%	1414
2026 Q1	$1.66K	Hold	317	–	–	﹤0.01%	1432
2025 Q4	$1.88K	Hold	317	–	–	﹤0.01%	1316
2025 Q3	$2.17K	Hold	317	–	–	﹤0.01%	1189
2025 Q2	$2.42K	Buy	+317	New	+$1.34K	﹤0.01%	985

Other funds holding SGMT

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

FRM

Fox Run Management Greenwich, Connecticut $603M AUM 32% 1-Year Est. Return

MMA

Miracle Mile Advisors Los Angeles, California $8.53B AUM 21.43% 1-Year Est. Return

APG

Abacus Planning Group Columbia, South Carolina $809M AUM 21.71% 1-Year Est. Return

RIA

RPG Investment Advisory Pleasanton, California $973M AUM 39.93% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Physician Wealth Advisors's SGMT Position: Q2 2026 in Review

Physician Wealth Advisors held its Sagimet Biosciences (SGMT) position steady in Q2 2026 at 317 shares worth $2.45K. The position accounts for ﹤0.01% of the portfolio, ranked #1414.

Physician Wealth Advisors first reported a position in SGMT in Q2 2025 and has held it in 5 quarters since. 17 funds tracked by Wall St. Rank hold SGMT as of Q2 2026.

Physician Wealth Advisors held 317 shares of Sagimet Biosciences worth $2.45K as of Q2 2026.
Physician Wealth Advisors left its Sagimet Biosciences share count unchanged in Q2 2026.
Sagimet Biosciences made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #1414 holding.
Physician Wealth Advisors first reported a position in Sagimet Biosciences in Q2 2025 and has held it in 5 quarters since.
17 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.